Enliven Therapeutics (ELVN) Shares Outstanding (Entity) (2019 - 2026)

Enliven Therapeutics (ELVN) Shares Outstanding (Entity) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Entity.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 253.35 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 139.80 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 62.54 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 214.24 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 113.02 Mn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn -
7 Royalty Pharma 33.72 Bn 35.84 Bn - 575.47 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 133.73 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 218.28 Mn
10 Enliven Therapeutics 4.31 Bn 3.41 Bn - 73.25 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 73.27 Mn
Mar 31, 2026 60.89 Mn
Dec 31, 2025 59.44 Mn
Sep 30, 2025 59.26 Mn
Jun 30, 2025 59.23 Mn
Mar 31, 2025 49.04 Mn
Dec 31, 2024 48.94 Mn
Sep 30, 2024 47.25 Mn
Jun 30, 2024 47.17 Mn
Mar 31, 2024 46.78 Mn
Dec 31, 2023 41.29 Mn
Sep 30, 2023 41.20 Mn
Jun 30, 2023 41.15 Mn
Mar 31, 2023 18.51 Mn
Dec 31, 2022 6.57 Mn
Sep 30, 2022 6.57 Mn
Jun 30, 2022 6.57 Mn
Mar 31, 2022 6.57 Mn
Dec 31, 2021 5.42 Mn
Sep 30, 2021 6.57 Mn